Is the patient's elevated total and free testosterone contributing to her diffuse hair loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Elevated Testosterone Cause Hair Loss in Women?

Elevated testosterone can contribute to female pattern hair loss (FPHL), but the relationship is complex—most women with FPHL have normal androgen levels, and isolated FPHL with normal testosterone should not be considered a sign of hyperandrogenism 1.

Understanding the Testosterone-Hair Loss Connection

The relationship between testosterone and female hair loss is neither consistent nor straightforward 1. Here's what the evidence shows:

Key Evidence Points:

Normal testosterone is common in FPHL:

  • Most women with frontal-central pattern hair loss have normal circulating androgen concentrations 1
  • FPHL has been documented even in women with complete absence of circulating androgens or lacking androgen receptors 1
  • Unlike male pattern baldness where DHT overproduction is clearly established, similar evidence for DHT overproduction in female pattern hair loss has not been demonstrated 1

When testosterone matters:

  • Women with significant androgenization may develop male-pattern (Hamilton pattern) hair loss with vertex thinning 1
  • Hyperandrogenic FPHL typically presents during young adulthood when androgen secretion is highest 1
  • In postmenopausal women with new-onset virilizing symptoms and testosterone >5 nmol/L, androgen-producing tumors must be excluded 2

The Estrogen-to-Androgen Ratio Hypothesis

A critical nuance: Even with normal absolute testosterone levels, a low estrogen-to-androgen ratio may trigger hair loss in genetically susceptible women 3. This means the relative balance matters more than absolute values in some cases.

Clinical Approach to Your Patient

Mandatory Assessment:

All women with FPHL require androgen evaluation 1:

  • Total testosterone using high-quality assay (LC/MS preferred or immunoassay with extraction/purification)
  • Free testosterone via equilibrium dialysis, ultracentrifugation, or calculated using SHBG
  • Look for other hyperandrogenism signs: hirsutism, acne, seborrhea, menstrual irregularities 4

Additional Recommended Testing:

  • Iron studies (ferritin—42% of FPHL patients show deficiency) 1
  • Vitamin D (62% show low levels) 1
  • Thyroid profile and TSH (hypothyroidism significantly associated with FPHL) 5, 6
  • Prolactin 1
  • Zinc levels 1

Treatment Algorithm

Start with topical minoxidil 5% (foam or solution) for all patients—this is first-line regardless of androgen status 1:

  • Apply once daily (foam) or twice daily (solution)
  • Expect transient shedding in first 2-8 weeks
  • Continue for minimum 12 months for optimal results

Add antiandrogens or 5α-reductase inhibitors when:

  1. Severe hair loss is present, OR
  2. Hyperandrogenism is documented 1

Critical Pitfall to Avoid:

Do not assume elevated testosterone is the sole cause without considering:

  • The estrogen-to-testosterone ratio (not just absolute values) 3
  • Thyroid dysfunction (significantly elevated TSH found in FPHL patients) 5, 6
  • Iron deficiency (present in 42% of cases) 1
  • The possibility that hair loss may occur despite normal androgens 1

Bottom Line for Your Patient

If her testosterone is elevated AND she has other signs of hyperandrogenism (hirsutism, acne, menstrual irregularities), then yes, the testosterone is likely contributing to her hair loss. However, if testosterone is only mildly elevated or she lacks other hyperandrogenic features, consider the broader hormonal context including estrogen levels, thyroid function, and nutritional deficiencies. The diagnosis remains primarily clinical based on hair loss pattern (centrifugal mid-scalp expansion or frontal "Christmas tree" pattern with preserved frontal hairline) 1.

References

Research

Hormone studies in females with androgenic hairloss.

Gynecologic and obstetric investigation, 1991

Research

Hormonal basis of male and female androgenic alopecia: clinical relevance.

Skin pharmacology : the official journal of the Skin Pharmacology Society, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.